Edesa Biotech Inc Cash Flow-to-Debt Ratio
Edesa Biotech Inc cash flow-to-debt ratio. Edesa Biotech Inc (EDSA) has a Cash Flow-to-Debt Ratio of -0.78x as of June 2026, meaning its operating cash flow of $-3.05 Million could theoretically repay -1% of its total liabilities ($3.91 Million) in one year. Check EDSA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Edesa Biotech Inc (2010–2025)
Cash flow-to-debt ratio of Edesa Biotech Inc from 2010 to 2025. Historical debt coverage capacity for Edesa Biotech Inc across 16 annual periods. Check Edesa Biotech Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Edesa Biotech Inc Cash Flow-to-Debt Ratio by Year (2010–2025)
Edesa Biotech Inc cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for Edesa Biotech Inc. For the full cash flow conversion analysis, see EDSA cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.79x | $-7.32 Million | $1.08 Million | ▼ -154.5% |
| 2024 | -2.67x | $-4.89 Million | $1.83 Million | ▲ +26.0% |
| 2023 | -3.60x | $-6.64 Million | $1.84 Million | ▲ +35.9% |
| 2022 | -5.62x | $-12.28 Million | $2.18 Million | ▲ +37.2% |
| 2021 | -8.95x | $-13.66 Million | $1.53 Million | ▼ -197.0% |
| 2020 | -3.01x | $-4.99 Million | $1.65 Million | ▲ +71.3% |
| 2019 | -10.50x | $-4.85 Million | $461.63K | ▼ -12.2% |
| 2018 | -9.35x | $-4.62 Million | $493.38K | ▲ +36.1% |
| 2017 | -14.64x | $-4.70 Million | $320.95K | ▼ -102.7% |
| 2016 | -7.22x | $-4.51 Million | $623.64K | ▼ -289.8% |
| 2015 | -1.85x | $-4.41 Million | $2.38 Million | ▼ -194.2% |
| 2014 | -0.63x | $-4.27 Million | $6.77 Million | ▼ -151.0% |
| 2013 | -0.25x | $-2.92 Million | $11.65 Million | ▲ +95.6% |
| 2012 | -5.70x | $-3.95 Million | $692.27K | ▲ +65.3% |
| 2011 | -16.44x | $-2.62 Million | $159.14K | ▼ -844.5% |
| 2010 | -1.74x | $-732.23K | $420.61K | — |